Cell4Cure AB
PrivateCompany Overview
Cell4Cure AB operates in Healthcare & Life Sciences and is based in Solna. It was founded in 2023.
Cell4Cure AB is a biotechnology company that develops autologous cell-based therapies for immune tolerance induction to treat autoimmune diseases and anti-drug antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cell4Cure AB Comparables
Compare Cell4Cure AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rezq Bio | 86% | |
| TolerogenixX GmbH | 81% | |
| Anokion | 77% |
For institutional investors. Book with your work email.
Cell4Cure AB Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cell4Cure AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cell4Cure AB's valuation, stock price, and market status.
Is Cell4Cure AB a public or private company?
Cell4Cure AB is a private company.
What is the current stock price of Cell4Cure AB?
Cell4Cure AB is a private company, so its shares have no public market price. Caplight tracks Cell4Cure AB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cell4Cure AB worth (valuation)?
Valuation information for Cell4Cure AB is not publicly available.
Can I buy Cell4Cure AB stock?
Cell4Cure AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cell4Cure AB's last funding round?
Funding round information for Cell4Cure AB is not publicly available.
Who are the main investors in Cell4Cure AB?
Investor information for Cell4Cure AB is not publicly disclosed.
Will Cell4Cure AB IPO soon?
No public IPO plans have been announced for Cell4Cure AB.
How can I track Cell4Cure AB secondary market activity?
Caplight tracks bids, offers, and trades in Cell4Cure AB's shares on secondary markets.